Xenon Pharmaceuticals
XENE
$43.75
Share price
1.74%
Change (1 day)
7.28%
Change (1 year)
Categories
Xenon Pharmaceuticals (XENE) - Total assets
Total assets on the balance sheet as of December 2023 : $0.96 B
According to Xenon Pharmaceuticals's latest financial reports the company's total assets are $0.96 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Xenon Pharmaceuticals - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.96 B | 27.93% |
| 2022-12-31 | $0.75 B | 31.84% |
| 2021-12-31 | $0.57 B | 202.35% |
| 2020-12-31 | $0.18 B | 28.09% |
| 2019-12-31 | $0.14 B | 20.64% |
| 2018-12-31 | $0.12 B | 165.45% |
| 2017-12-31 | $46.12 M | -31.66% |
| 2016-12-31 | $67.48 M | 5.53% |
| 2015-12-31 | $63.94 M | -26.85% |
| 2014-12-31 | $87.41 M | 60.44% |
| 2013-12-31 | $54.48 M | -13.93% |
| 2012-12-31 | $63.3 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Coherus BioSciences
CHRS | $0.62 B | -34.74% | 🇺🇸 USA |
 Atara Biotherapeutics ATRA | $0.16 B | -82.85% | 🇺🇸 USA |